Literature DB >> 28750468

Quality of Life in Sarcoidosis.

Marc A Judson1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28750468     DOI： 10.1055/s-0037-1602589

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN： 1069-3424            Impact factor:   3.119


× No keyword cloud information.
  8 in total

1.  Cognitive Difficulties and Health-Related Quality of Life in Sarcoidosis: An Analysis of the GRADS Cohort.

Authors:  Karin F Hoth; Jacob Simmering; Anna Croghan; Nabeel Y Hamzeh
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

2.  Daytime Sleepiness in Patients Diagnosed with Sarcoidosis Compared with the General Population.

Authors:  Andreas Hinz; Kristina Geue; Markus Zenger; Hubert Wirtz; Andrea Bosse-Henck
Journal:  Can Respir J       Date:  2018-07-10       Impact factor: 2.409

3.  Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis.

Authors:  Catharina C Moor; Yasmin Gür-Demirel; Marlies S Wijsenbeek
Journal:  J Pers Med       Date:  2019-05-05

Review 4.  Comprehensive Care for Patients with Sarcoidosis.

Authors:  Catharina C Moor; Vivienne Kahlmann; Daniel A Culver; Marlies S Wijsenbeek
Journal:  J Clin Med       Date:  2020-02-01       Impact factor: 4.241

Review 5.  Managing Fatigue in Patients With Interstitial Lung Disease.

Authors:  Vivienne Kahlmann; Catharina C Moor; Marlies S Wijsenbeek
Journal:  Chest       Date:  2020-05-07       Impact factor: 9.410

6.  FeV1 and BMI influence King's Sarcoidosis Questionnaire score in sarcoidosis patients.

Authors:  Björn Christian Frye; Laura Potasso; Erik Farin-Glattacker; Surrinder Birring; Joachim Müller-Quernheim; Jonas Christian Schupp
Journal:  BMC Pulm Med       Date:  2021-12-03       Impact factor: 3.317

7.  Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners.

Authors:  C C Moor; M J G van Manen; P M van Hagen; J R Miedema; L M van den Toorn; Y Gür-Demirel; A P C Berendse; J A M van Laar; M S Wijsenbeek
Journal:  Lung       Date:  2018-08-07       Impact factor: 2.584

Review 8.  Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.

Authors:  Marc A Judson
Journal:  F1000Res       Date:  2019-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.